Erste Asset Management Gmb H Biotechnology

Erste Asset Management Gmb H

$7.79 Trillion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
RARE Ultragenyx Pharmaceutical Inc.	$1.91B	$568 Million 0.01% of portfolio	15,010	Q2 2022 Reduced 82.89%
ZLAB Zai Lab LTD	$3.7B	$563 Million 0.01% of portfolio	15,100	Q4 2021 Reduced 27.81%
VCYT Veracyte, Inc.	$1.69B	$512 Million 0.01% of portfolio	17,000	Q3 2024 New
BEAM Beam Therapeutics Inc.	$1.47B	$482 Million 0.01% of portfolio	21,700	Q4 2022 Added 45.64%
IBRX Immunity Bio, Inc.	$1.2B	$480 Million 0.01% of portfolio	153,000	Q3 2024 New
LGND Ligand Pharmaceuticals Inc	$2.24B	$463 Million 0.01% of portfolio	4,300	Q2 2022 Reduced 40.28%
HRMY Harmony Biosciences Holdings, Inc.	$2.17B	$435 Million 0.01% of portfolio	13,100	Q3 2024 New
DAWN Day One Biopharmaceuticals, Inc.	$530M	$413 Million 0.01% of portfolio	51,200	Q3 2024 New
DNLI Denali Therapeutics Inc.	$1.92B	$398 Million 0.01% of portfolio	26,900	Q4 2023 Reduced 91.96%
GLPG Galapagos Nv	$2.03B	$356 Million 0.0% of portfolio	14,000	Q1 2022 Sold Out
RCKT Rocket Pharmaceuticals, Inc.	$243M	$339 Million 0.0% of portfolio	44,700	Q3 2022 Reduced 62.64%
AUTL Autolus Therapeutics PLC	$237M	$324 Million 0.0% of portfolio	195,000	Q1 2023 Added 62.5%
BCRX Biocryst Pharmaceuticals Inc	$1.59B	$314 Million 0.0% of portfolio	40,000	Q3 2024 New
EYPT Eye Point Pharmaceuticals, Inc.	$356M	$292 Million 0.0% of portfolio	50,000	Q4 2024 New
ADPT Adaptive Biotechnologies Corp	$1.52B	$274 Million 0.0% of portfolio	35,700	Q4 2020 Reduced 15.0%
SAGE Sage Therapeutics, Inc.	$521M	$236 Million 0.0% of portfolio	28,500	Q2 2022 Reduced 19.72%
KROS Keros Therapeutics, Inc.	$354M	$223 Million 0.0% of portfolio	20,700	Q3 2022 Reduced 72.46%
RXRX Recursion Pharmaceuticals, Inc.	$1.13B	$195 Million 0.0% of portfolio	33,500	Q3 2024 New
VIR Vir Biotechnology, Inc.	$764M	$193 Million 0.0% of portfolio	28,800	Q4 2021 Added 15.63%
NTLA Intellia Therapeutics, Inc.	$971M	$178 Million 0.0% of portfolio	22,100	Q1 2023 Reduced 0.2%
ABCL Ab Cellera Biologics Inc.	$1.43B	$143 Million 0.0% of portfolio	62,000	Q3 2024 New
BCYC Bicycle Therapeutics PLC	$248M	$126 Million 0.0% of portfolio	14,000	Q3 2024 New
REPL Replimune Group, Inc.	$153M	$124 Million 0.0% of portfolio	11,900	Q3 2024 New
RGNX Regenxbio Inc.	$395M	$102 Million 0.0% of portfolio	13,000	Q3 2024 New
SANA Sana Biotechnology, Inc.	$976M	$68.4 Million 0.0% of portfolio	40,000	Q3 2024 New
MRVI Maravai Lifesciences Holdings, Inc.	$356M	$67 Million 0.0% of portfolio	28,400	Q3 2024 New
RLAY Relay Therapeutics, Inc.	$442M	$62.8 Million 0.0% of portfolio	23,100	Q3 2024 New
ALLO Allogene Therapeutics, Inc.	$217M	$48.7 Million 0.0% of portfolio	31,400	Q4 2021 Added 29.94%
ALEC Alector, Inc.	$148M	$24.5 Million 0.0% of portfolio	19,000	Q3 2024 New
TECH Bio Techne Corp	$2.29B	$0 0.0% of portfolio	0	Q1 2025 New
MRNA Moderna, Inc.	$13.3B	$0 0.0% of portfolio	0	Q1 2025 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Erste Asset Management Gmb H with notifications on news.